These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31642769)

  • 21. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
    Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.
    Spengler G; Kincses A; Gajdács M; Amaral L
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28294992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations.
    Sun J; Deng Z; Yan A
    Biochem Biophys Res Commun; 2014 Oct; 453(2):254-67. PubMed ID: 24878531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Alharbe R; Almansour A; Kwon DH
    Int J Med Microbiol; 2017 Oct; 307(7):409-414. PubMed ID: 28781060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Essential Oils in the Inhibition of Efflux Pumps and Reversion of Bacterial Resistance to Antimicrobials.
    Agreles MAA; Cavalcanti IDL; Cavalcanti IMF
    Curr Microbiol; 2021 Oct; 78(10):3609-3619. PubMed ID: 34432112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology-driven strategies to enhance the treatment of drug-resistant bacterial infections.
    Zhang J; Liu M; Guo H; Gao S; Hu Y; Zeng G; Yang D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1968. PubMed ID: 38772565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
    Vila J; Martínez JL
    Curr Drug Targets; 2008 Sep; 9(9):797-807. PubMed ID: 18781925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance.
    Lin MF; Lin YY; Tu CC; Lan CY
    J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotics-Peptide Conjugates Against Multidrug-resistant Bacterial Pathogens.
    David AA; Park SE; Parang K; Tiwari RK
    Curr Top Med Chem; 2018; 18(22):1926-1936. PubMed ID: 30499392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanobiotechnological Approaches Against Multidrug Resistant Bacterial Pathogens: An Update.
    Shaikh S; Shakil S; Abuzenadah AM; Rizvi SM; Roberts PM; Mushtaq G; Kamal MA
    Curr Drug Metab; 2015; 16(5):362-70. PubMed ID: 26419545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restraining the multidrug efflux transporter STY4874 of Salmonella Typhi by reserpine and plant extracts.
    Tariq A; Sana M; Shaheen A; Ismat F; Mahboob S; Rauf W; Mirza O; Iqbal M; Rahman M
    Lett Appl Microbiol; 2019 Sep; 69(3):161-167. PubMed ID: 31267555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in Engineered Nano-Biosensors for Bacteria Diagnosis and Multidrug Resistance Inhibition.
    Xia Q; Jiang H; Liu X; Yin L; Wang X
    Biosensors (Basel); 2024 Jan; 14(2):. PubMed ID: 38391978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.
    El Zowalaty ME; Al Thani AA; Webster TJ; El Zowalaty AE; Schweizer HP; Nasrallah GK; Marei HE; Ashour HM
    Future Microbiol; 2015; 10(10):1683-706. PubMed ID: 26439366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance].
    Aygül A
    Mikrobiyol Bul; 2015 Apr; 49(2):278-91. PubMed ID: 26167829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multi-drug efflux pumps and antibiotic resistance in Acinetobacter baumannii].
    Opazo AC; Mella SM; Domínguez MY; Bello HT; González GR
    Rev Chilena Infectol; 2009 Dec; 26(6):499-503. PubMed ID: 20098782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of efflux pumps in Bacteroides fragilis resistance to antibiotics.
    Ghotaslou R; Yekani M; Memar MY
    Microbiol Res; 2018 May; 210():1-5. PubMed ID: 29625653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.
    Jamshidi S; Sutton JM; Rahman KM
    Future Med Chem; 2016; 8(2):195-210. PubMed ID: 26824720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the multidrug efflux pump LmrS from Staphylococcus aureus by cumin spice Cuminum cyminum.
    Kakarla P; Floyd J; Mukherjee M; Devireddy AR; Inupakutika MA; Ranweera I; Kc R; 'Shrestha U; Cheeti UR; Willmon TM; Adams J; Bruns M; Gunda SK; Varela MF
    Arch Microbiol; 2017 Apr; 199(3):465-474. PubMed ID: 27830269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
    Pagès JM; Amaral L; Fanning S
    Curr Med Chem; 2011; 18(19):2969-80. PubMed ID: 21651484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.